Cargando…
Pharmacogenomics: Current State-of-the-Art
The completion of the human genome project 10 years ago was met with great optimism for improving drug therapy through personalized medicine approaches, with the anticipation that an era of genotype-guided patient prescribing was imminent. To some extent this has come to pass and a number of key pha...
Autores principales: | Carr, Daniel F., Alfirevic, Ana, Pirmohamed, Munir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094941/ https://www.ncbi.nlm.nih.gov/pubmed/24865298 http://dx.doi.org/10.3390/genes5020430 |
Ejemplares similares
-
Pharmacogenomics for Primary Care: An Overview
por: Rollinson, Victoria, et al.
Publicado: (2020) -
Drug Induced Hypersensitivity and the HLA Complex
por: Alfirevic, Ana, et al.
Publicado: (2010) -
Ethnic Diversity and Warfarin Pharmacogenomics
por: Asiimwe, Innocent G., et al.
Publicado: (2022) -
Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components
por: Turner, Richard Myles, et al.
Publicado: (2019) -
State of Art of Cancer Pharmacogenomics in Latin American Populations
por: López-Cortés, Andrés, et al.
Publicado: (2017)